Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

49.97 +1.74 (+3.61%)

Streaming Delayed Price Updated: 1:44 PM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Large-Cap Stocks In Trouble - Sunday, Nov. 17 ↗

November 17, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers ↗

November 17, 2024

10 worst performing large-cap stocks last week: MPWR, SMCI, MRNA, LDOS, MNDY, PCVX, BAH, ABBV, CACI, XPEV. Check if they're in your portfolio.

Via Benzinga

Deciphering Disruption: Inside Cathie Wood's Latest Plays

November 16, 2024

Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.

Via MarketBeat

Topics Artificial Intelligence ETFs

Demystifying Moderna: Insights From 16 Analyst Reviews ↗

November 15, 2024

Via Benzinga

Smart Money Is Betting Big In MRNA Options ↗

November 08, 2024

Via Benzinga

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older

November 08, 2024

Via ACCESSWIRE

Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates

November 07, 2024

Via ACCESSWIRE

Moderna Shares Are Dipping Today: What's Going On? ↗

November 15, 2024

Shares of Moderna Inc. (NASDAQ: MRNA) are trading lower after President-elect Donald Trump nominated Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS). Here's what you...

Via Benzinga

Topics Government

Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth ↗

November 15, 2024

To gain an edge, this is what you need to know today.

Via Benzinga

European And US Vaccine Stocks Are Under Pressure - Here's WHy ↗

November 15, 2024

Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid market shifts.

Via Benzinga

Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS ↗

November 15, 2024

President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

Via Investor's Business Daily

Topics Government

WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill ↗

November 15, 2024

Trump's decision to appoint Kennedy, known for his vaccine skepticism, has sparked significant attention.

Via Benzinga

Topics Government

US Stocks Likely To Open In Red After Jerome Powell Says No Need To Be 'In A Hurry' On Rate Cuts: Tesla, TSMC And Domino's In Focus ↗

November 15, 2024

U.S. stocks could open on a negative note on Friday after the Federal Reserve chair Jerome Powell's comments on Thursday that the economy is showing enough strength that there is no need to be "in a...

Via Benzinga

Topics Economy

Palantir, Moderna, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

November 14, 2024

US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling by nearly 0.6% respectively.

Via Benzinga

Topics Stocks

Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower ↗

November 14, 2024

Trump may appoint Robert F. Kennedy Jr. as HHS Secretary, stirring mixed reactions. Kennedy's views on vaccines could reshape policies and affect vaccine stocks.

Via Benzinga

Topics Government

The Oncology Bet Is Already Paying Off For Pfizer ↗

November 13, 2024

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14%...

Via Benzinga

Bird Flu Puts Teen In Critical Condition As Canada Reports First Human Case: What You Need To Know ↗

November 13, 2024

Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.

Via Benzinga

Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year

November 12, 2024

Via ACCESSWIRE

The Week Kamala Harris Lost (Nov 4-8), These Large Cap Stocks Lost Big ↗

November 11, 2024

Kamala Harris lost 2024 US election, 10 large-cap stocks performed poorly: Moderna, Honda, Akamai, ADS, AstraZeneca, Pinterest, MercadoLibre, First Solar, POSCO, Floor & Decor

Via Benzinga

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn ↗

November 08, 2024

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over upcoming COVID and RSV sales.

Via Benzinga

Topics Earnings

2 Biotech Stocks You Can Buy Hand Over Fist This Month ↗

November 08, 2024

Both stocks have made significant breakthroughs.

Via The Motley Fool

Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction' ↗

November 07, 2024

Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda.

Via Benzinga

Topics Government

Moderna (MRNA) Q3 2024 Earnings Call Transcript ↗

November 07, 2024

MRNA earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Moderna Q3 Revenue Beats On Updated COVID-19 Vaccine, Slashes Expenses For 2024 ↗

November 07, 2024

Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.

Via Benzinga

Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing? ↗

November 07, 2024

The company reported just $10 million in sales of its RSV vaccine, mResvia, widely missing expectations.

Via Investor's Business Daily

Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

November 07, 2024

Via Benzinga

Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped ↗

November 06, 2024

On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. (NASDAQ:MRNA) and Square Inc. (NYSE:SQ). The Moderna Trade

Via Benzinga

Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr. ↗

November 06, 2024

Robert Kennedy Jr. revealed Trump's directive to tackle health agency corruption, promote science, and end chronic disease.

Via Benzinga

Topics Government

These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over ↗

November 06, 2024

Perhaps this list is a good place to start bargain-hunting.

Via The Motley Fool

Topics Stocks

Is It Time to Buy October's Worst-Performing Nasdaq Stocks? ↗

November 06, 2024

Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.

Via The Motley Fool

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.